Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 6(5): e20012, 2011.
Article in English | MEDLINE | ID: mdl-21655328

ABSTRACT

The Saccharomyces cerevisiae High-Osmolarity Glycerol (HOG) pathway is a conserved mitogen-activated protein kinase (MAPK) signal transduction system that often serves as a model to analyze systems level properties of MAPK signaling. Hog1, the MAPK of the HOG-pathway, can be activated by various environmental cues and it controls transcription, translation, transport, and cell cycle adaptations in response to stress conditions. A powerful means to study signaling in living cells is to use kinase inhibitors; however, no inhibitor targeting wild-type Hog1 exists to date. Herein, we describe the design, synthesis, and biological application of small molecule inhibitors that are cell-permeable, fast-acting, and highly efficient against wild-type Hog1. These compounds are potent inhibitors of Hog1 kinase activity both in vitro and in vivo. Next, we use these novel inhibitors to pinpoint the time of Hog1 action during recovery from G(1) checkpoint arrest, providing further evidence for a specific role of Hog1 in regulating cell cycle resumption during arsenite stress. Hence, we describe a novel tool for chemical genetic analysis of MAPK signaling and provide novel insights into Hog1 action.


Subject(s)
Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Mitogen-Activated Protein Kinases/metabolism , Saccharomyces cerevisiae Proteins/antagonists & inhibitors , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Signal Transduction/drug effects , Enzyme Inhibitors/chemistry , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Models, Molecular , Molecular Structure
2.
Nature ; 469(7329): 207-11, 2011 Jan 13.
Article in English | MEDLINE | ID: mdl-21150900

ABSTRACT

Ongoing efforts within synthetic and systems biology have been directed towards the building of artificial computational devices using engineered biological units as basic building blocks. Such efforts, inspired in the standard design of electronic circuits, are limited by the difficulties arising from wiring the basic computational units (logic gates) through the appropriate connections, each one to be implemented by a different molecule. Here, we show that there is a logically different form of implementing complex Boolean logic computations that reduces wiring constraints thanks to a redundant distribution of the desired output among engineered cells. A practical implementation is presented using a library of engineered yeast cells, which can be combined in multiple ways. Each construct defines a logic function and combining cells and their connections allow building more complex synthetic devices. As a proof of principle, we have implemented many logic functions by using just a few engineered cells. Of note, small modifications and combination of those cells allowed for implementing more complex circuits such as a multiplexer or a 1-bit adder with carry, showing the great potential for re-utilization of small parts of the circuit. Our results support the approach of using cellular consortia as an efficient way of engineering complex tasks not easily solvable using single-cell implementations.


Subject(s)
Bioengineering , Logic , Models, Biological , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/metabolism , Systems Biology/methods , Candida albicans , Cell Compartmentation , Colony Count, Microbial , Doxycycline/pharmacology , Estradiol/pharmacology , Galactose/pharmacology , Mating Factor , Peptides/metabolism , Peptides/pharmacology , Pheromones/metabolism , Pheromones/pharmacology , Saccharomyces cerevisiae/drug effects , Sodium Chloride/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL